Andrey Shaw

12PUBLICATIONS
81CO-AUTHORS
Molecular targetsInnate immunityMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 25, 2026
VSIG4 Restricts Hepatocellular Carcinoma Control by Suppressing Tumor-Specific CD8+ T-cell Immunity in the Tumor Microenvironment.

Jinglong Guo, Siddheshvar Bhela, Monica Sharma

|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Nov 06, 2024
Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade.

Mayra Cruz Tleugabulova, Sandra P Melo, Aaron Wong

|Jun 13, 2024
Diffusion tensor MRI is sensitive to fibrotic injury in a mouse model of oxalate-induced chronic kidney disease.

Rohan S Virgincar, Aaron K Wong, Kai H Barck

|Jan 20, 2024
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists.

Matthew G Romei, Brandon Leonard, Zachary B Katz

|Sep 21, 2023
Nucleolar condensates: A cellular machinery necessary for T cell activation.

Monica Sharma, Andrey S Shaw

Pageof 2